Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Dimitrakopoulos

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survivalAnna G Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 4, 2011
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survivalAnna G Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, et al.
Anticancer Research|February 5, 2020
Genetic Variations of <i>VEGFA</i> Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal CarcinomaElizabeth Psoma, Georgia-Angeliki Koliou, Foteinos-Ioannis Dimitrakopoulos, et al.
Cancers|January 8, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer PatientsArgyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, et al.
Molecular Oncology|November 22, 2024
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approachDimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, et al.
Cancers|April 3, 2021
Genetic Variation in the <i>Vascular Endothelial Growth Factor (VEGFA</i>) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck CancerFoteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Vassiliki Kotoula, et al.
Cancers|October 23, 2021
Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer PatientsFoteinos-Ioannis Dimitrakopoulos, Anastasia E Kottorou, Kristen Rodgers, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Therapeutic Advances in Medical Oncology|September 15, 2022
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre studyFoteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, et al.
Breast (Edinburgh, Scotland)|January 4, 2024
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytesFoteinos-Ioannis Dimitrakopoulos, Anna Goussia, Georgia-Angeliki Koliou, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survivalAnna G Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 4, 2011
The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survivalAnna G Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, et al.
Anticancer Research|February 5, 2020
Genetic Variations of <i>VEGFA</i> Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal CarcinomaElizabeth Psoma, Georgia-Angeliki Koliou, Foteinos-Ioannis Dimitrakopoulos, et al.
Cancers|January 8, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer PatientsArgyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, et al.
Molecular Oncology|November 22, 2024
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approachDimitrios Papakonstantinou, Argyro Roumeliotou, Evangelia Pantazaka, et al.
Cancers|April 3, 2021
Genetic Variation in the <i>Vascular Endothelial Growth Factor (VEGFA</i>) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck CancerFoteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Vassiliki Kotoula, et al.
Cancers|October 23, 2021
Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer PatientsFoteinos-Ioannis Dimitrakopoulos, Anastasia E Kottorou, Kristen Rodgers, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Therapeutic Advances in Medical Oncology|September 15, 2022
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre studyFoteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, et al.
Breast (Edinburgh, Scotland)|January 4, 2024
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytesFoteinos-Ioannis Dimitrakopoulos, Anna Goussia, Georgia-Angeliki Koliou, et al.
Pageof 6